California Healthcare Institute Submits Statement to California Institute for Regenerative Medicine.LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif. -- The California Healthcare Institute (CHI) today submitted comments to the Independent Citizens Oversight Committee (ICOC ICOC Independent Citizens Oversight Committee (San Diego, California) ICOC International Church of Christ ICOC International Code of Conduct ICOC Integrated Combat Operations Center ICOC Instructions for Commodores of Convoys ) of the California Institute for Regenerative Medicine's (CIRM CIRM Certified in Integrated Resource Management CIRM California Institute for Regenerative Medicine CIRM Comité International Radio-Maritime (International Radio-Medical Center) CIRM Corporate Infrastructure Resource Management ) revised interim regulations addressing Intellectual Property Policy for For-Profit Organizations (IPPFPO) as released for public comment on Sept. 20, 2007. CHI is a non-profit public policy research organization for California's biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. industry. "CHI believes a strong intellectual property policy will advance CIRM-funded stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research and, ultimately, treatments for millions of people here in California and worldwide. This, in turn, will improve California's healthcare system, benefit the California economy, and further promote the state's biotechnology industry as a global leader. We hope that the ICOC will give careful consideration to our comments and incorporate them into the final policy," said David L. Gollaher, Ph.D., CHI president and chief executive officer. CHI's comments centered around the success of the federal Bayh-Dole Act The Bayh-Dole Act or University and Small Business Patent Procedures Act is a piece of United States legislation from 1980. Bayh-Dole is codified in 35 U.S.C. 200-212[1], and is implemented by 37 C.F.R. 401[2]. , legislation that created a single, uniform national policy designed to encourage private investment that would bring government funded discoveries to the marketplace, and the belief that this proven system offers a model to California. CHI believes that regulation should focus on intent of the law established with the passage of Proposition 71 - to "improve the California healthcare system and reduce the long-term health care cost burden on California through the development of therapies that treat diseases and injuries with the ultimate goal to cure them" (Prop. 71, Section 3.) Current provisions in the regulation that address pricing and access, revenue sharing revenue sharing Funding arrangement in which one government unit grants a portion of its tax income to another government unit. For example, provinces or states may share revenue with local governments, or national governments may share revenue with provinces or states. , and march-in rights should not be the subject of policies and regulations pertaining to Prop. 71 and will create substantial disincentives to commercial interest in licensing CIRM-funded inventions. CHI's full comments to the revised CIRM IPPFPO issued Sept. 20, 2007 are available at www.chi.org. CHI represents more than 250 leading medical device, biotechnology, diagnostics and pharmaceutical companies and public and private academic biomedical research organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion